REPLIGEN CORP Property, Plant and Equipment, Gross
REPLIGEN CORP (RGEN) had Property, Plant and Equipment, Gross of $390.50 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-02-26
- 2025-12-31: Property, Plant and Equipment, Gross $390.50M.
- 2025-09-30: Property, Plant and Equipment, Gross $382.51M.
- 2025-06-30: Property, Plant and Equipment, Gross $377.13M.
- 2025-03-31: Property, Plant and Equipment, Gross $367.47M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2025-12-31 | $390.50M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $382.51M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $377.13M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $367.47M 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $360.20M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $355.71M 10-Q · filed 2024-11-18 | |
| 2024-06-30 | $347.82M 10-Q/A · filed 2024-11-18 | |
| 2024-03-31 | $341.49M 10-Q/A · filed 2024-11-18 | |
| 2023-12-31 | $336.16M 10-K · filed 2025-03-14 | |
| 2023-09-30 | $321.37M 10-Q/A · filed 2024-11-18 | |
| 2023-06-30 | $311.47M 10-Q/A · filed 2024-11-18 | |
| 2023-03-31 | $293.07M 10-Q/A · filed 2024-11-18 | |
| 2022-12-31 | $282.98M 10-Q/A · filed 2024-11-18 | |
| 2022-09-30 | $258.36M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $247.77M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $222.98M 10-Q · filed 2022-04-27 | |
| 2021-12-31 | $195.68M 10-K · filed 2023-02-22 | |
| 2021-09-30 | $164.34M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $139.85M 10-Q · filed 2021-07-27 | |
| 2021-03-31 | $122.73M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $115.93M 10-K · filed 2022-02-17 | |
| 2020-09-30 | $100.17M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $92.96M 10-Q · filed 2020-07-30 | |
| 2020-03-31 | $87.63M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $83.83M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $75.87M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $69.55M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $64.14M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $60.49M 10-K · filed 2020-02-26 | |
| 2018-09-30 | $56.37M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $49.72M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $47.68M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $46.22M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $44.47M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $37.08M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $35.26M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $34.29M 10-K · filed 2018-02-22 | |
| 2016-09-30 | $33.93M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $31.94M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $31.03M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $30.30M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $29.72M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $29.50M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $28.81M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $28.34M 10-K · filed 2016-02-25 | $28.34M 10-K · filed 2015-03-17 |
| 2014-09-30 | $27.00M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $25.97M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $25.36M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $24.80M 10-K · filed 2015-03-17 | |
| 2013-09-30 | $24.16M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $21.09M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $20.57M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $20.28M 10-K · filed 2014-03-14 | |
| 2012-09-30 | $19.89M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $18.91M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $19.11M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $18.61M 10-K · filed 2013-03-15 | |
| 2011-09-30 | $9.29M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $9.12M 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $8.95M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |